Cost-Effectiveness of the EdAl (Educació en Alimentació) Program: : A Primary School-Based Study to Prevent Childhood Obesity

We sincerely thank all the participants in this study, their families, and the schools. # MC and ELL contributed equally to this manuscript. This work was supported by a fellowship granted to MC from the “Santander CRUE CEPYME Prácticas en Empresa”. D.M. was partially supported by grants from the Instituto de Salud Carlos III-ISCIII (Spanish Government) cofunded by FEDER funds=European Regional Development Fund (ERDF) - a way to build Europe (References: RD12=0036=0056, PI11=02090 and PI16=01254) and from the Agència de Gestió d’Ajuts Universitaris i de Recerca (2014SGR756) and RecerCaixa 2015 (2015ACUP00129). Conflicts of interest: None declared. Supplementary data related to this article can be found at https:== doi.org=10.2188=jea.JE20170111.Peer reviewedPublisher PD

Approaches to manage 'affordability' of high budget impact medicines in key EU countries

Background: The launch of hepatitis C (HCV) drugs such as sofosbuvir or ledipasvir has fostered the question of affordability of novel high budget impact therapies even in countries with high domestic product. European countries have developed a variety of mechanisms to improve affordability of such therapies, including 'affordability thresholds', price volume agreements or caps on individual product sales, and special budgets for innovative drugs. While some of these mechanisms may help limit budget impact, there are still significant progresses to be made in the definition and implementation of approaches to ensure affordability, especially in health systems where the growth potential in drug spending and/or in the patient contribution to health insurance are limited. Objectives: In this article, we will review how seven countries in western Europe are approaching the question of affordability of novel therapies and are developing approaches to continue to reward new sciences while limiting budget impact. We will also discuss the question of affordability of cost-effective but hugely expensive therapies and the implications for payers and for the pharmaceutical industry. Results: There is clearly not one solution that is used consistently across countries but rather a number of 'tools' that are combined differently in each country. This illustrates the difficulty of managing affordability within different legal frameworks and within different health care system architectures.</p

Effect of space allowance and mixing on growth performance and body lesions of grower-finisher pigs in pens with a single wet-dry feeder

Publicationhistory: Accepted - 17 December 2020; Published online - 6 January 2021.Background: Low space allowance (SA) and mixing may result in reduced growth performance (GP) and animal welfare issues because of adverse social behaviours directed to pen mates. This could be exacerbated in pens with single space feeders owing to social facilitation of feeding behaviour. The present study aimed to investigate the effect of SA and mixing on GP and body lesions (BL) in pens with one single space wet-dry feeder. Results: Two experiments were conducted on grower-finisher pigs from 10 to 21 weeks of age. In Exp1, pigs (N = 216) were assigned to three SA; 0.96m2/pig (n = 6 pens; 10 pigs/pen; SA96), 0.84m2/pig (n = 6; 12 pigs/pen; SA84) and 0.72m2/pig (n = 6; 14 pigs/pen; SA72), in a randomized design. In Exp2, pigs (N = 230) were used in a 2 × 2 factorial randomized design considering SA and mixing as treatments. Pigs were assigned to two SA; 0.96m2/pig (n = 10 pens; 10 pigs/pen; SA96) and 0.78 m2/pig (n = 10; 13 pigs/pen; SA78) and were either mixed or not at the entry to the finishing facility. GP was not affected by SA (P > 0.05) in either experiment. In Exp2, non-mixed pigs were 5.4 kg heavier (P < 0.001), gained 74 g more per day (P = 0.004), consumed 101.8 g more of feed per day (P = 0.007) and tended to have higher feed efficiency (P = 0.079) than mixed pigs from 11 to 21 weeks of age. Number of BL was affected by SA in both experiments. In Exp1, SA72 pigs had 74.4 and 97.4% more BL than SA96 and SA84 pigs at 20 weeks of age respectively (P < 0.01). In Exp2, SA78 pigs had 48.6, 43.6 and 101.3% more BL than SA96 pigs at 12, 16 and 21 weeks of age respectively (P < 0.05). Mixing did not affect the number of BL from 12 to 21 weeks of age in Exp2 (P > 0.05). Conclusion: Mixing had a considerable effect on growth performance thus, strategies to avoid or mitigate mixing should be considered. Although space allowance had no effect on growth performance, high number of body lesions in the lower space allowance indicates that space allowances equal or below 0.78 m2/pig are detrimental to the welfare of pigs despite following the EU legislation.Jordi Camp Montoro was supported by the Teagasc Walsh Scholarship Scheme grant-in-aid project Introducing new feeding programs and facilities for Irish finishing pigs ref. 0415. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript

Blood and faecal biomarkers to assess dietary energy, protein and amino acid efficiency of utilization by growing and finishing pigs.

Publication history: Accepted - 20 June 2022; Published online - 4 July 2022Background: Diet evaluation and optimization is a slow and expensive process and it is not possible to do it at a farm level. This study aimed to use the blood serum metabolite (BSM) and faecal volatile fatty acid (VFA) profles as potential biomarkers to identify changes in protein, amino acid and energy dietary content in growing and fnishing pig diets at farm level. Results: Two studies were conducted. The frst study (S1) included 20 pens of 11 pigs (87.0±4.10 kg; 18 weeks old) assigned to 5 diets: control (C1), high or low crude protein (HP1 and LP1, respectively), and high or low net energy (HE1 and LE1, respectively). The second study (S2) included 28 pens of 11 pigs (41.3±2.60 kg; 12 weeks old) assigned to 7 diets: control (C2), high or low crude protein (HP2 and LP2, respectively), high or low amino acid (HA2 and LA2, respectively), and high or low net energy (HE2 and LE2, respectively). Pigs were followed for 10 (S1) and 20 (S2) days, and blood and faecal samples were collected at 20 (S1) and 14 (S2) weeks of age. Data were analysed using gen‑ eral linear models and receiver operating characteristic curve analysis. Urea nitrogen showed the best results as a biomarker. Urea nitrogen was higher in pigs fed high protein diets, HP1 (13.6±0.95 mg/dL) and HP2 (11.6±0.61), compared to those fed low protein diets, LP1 (6.0±0.95) and LP2 (5.2±0.61; P<0.001), showing good discrimination ability (Area under the curve (AUC)=98.4 and 100%, respectively). These diferences were not observed between diets LA2 (6.5±0.61) and HA2 (8.7±0.61; P>0.05; AUC=71.9%), which were formulated based on the ideal protein profle but with no excess of protein. Creatinine, triglycerides, branched-chain fatty acids, albumin, propionic acid, and cholesterol showed diferences between at least 2 diets but only in one of the studies. Conclusions: Urea nitrogen showed high accuracy to detect excess of crude protein in growing and fnishing pig diets. Other biomarkers like BCFA showed promising results and need to be further studied.Jordi Camp Montoro was supported by the Teagasc Walsh Scholarship Scheme grant-in-aid project Introducing new feeding programs and facilities for Irish finishing pigs ref 0415. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript

EXCESS workshop: Descriptions of rising low-energy spectra

International audienceMany low-threshold experiments observe sharply rising event rates of yet unknown origins below a few hundred eV, and larger than expected from known backgrounds. Due to the significant impact of this excess on the dark matter or neutrino sensitivity of these experiments, a collective effort has been started to share the knowledge about the individual observations. For this, the EXCESS Workshop was initiated. In its first iteration in June 2021, ten rare event search collaborations contributed to this initiative via talks and discussions. The contributing collaborations were CONNIE, CRESST, DAMIC, EDELWEISS, MINER, NEWS-G, NUCLEUS, RICOCHET, SENSEI and SuperCDMS. They presented data about their observed energy spectra and known backgrounds together with details about the respective measurements. In this paper, we summarize the presented information and give a comprehensive overview of the similarities and differences between the distinct measurements. The provided data is furthermore publicly available on the workshop’s data repository together with a plotting tool for visualization